Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

1.

Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study.

Arenas-Pinto A, Milinkovic A, Peppa D, McKendry A, Maini M, Gilson R.

BMC Infect Dis. 2015 Mar 21;15(1):138. doi: 10.1186/s12879-015-0889-9.

2.

Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance.

King EM, Gilson R, Beddows S, Soldan K, Panwar K, Young C, Jit M, Edmunds WJ, Sonnenberg P.

Sex Transm Infect. 2015 Apr 17. pii: sextrans-2014-051955. doi: 10.1136/sextrans-2014-051955. [Epub ahead of print]

3.

Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies.

King EM, Gilson R, Beddows S, Soldan K, Panwar K, Young C, Prah P, Jit M, Edmunds WJ, Sonnenberg P.

Br J Cancer. 2015 Apr 28;112(9):1585-93. doi: 10.1038/bjc.2015.90. Epub 2015 Mar 19.

PMID:
25791874
4.

Active recall to increase HIV and STI testing: a systematic review.

Desai M, Woodhall SC, Nardone A, Burns F, Mercey D, Gilson R.

Sex Transm Infect. 2015 Mar 10. pii: sextrans-2014-051930. doi: 10.1136/sextrans-2014-051930. [Epub ahead of print] Review.

PMID:
25759476
5.

Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.

Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA.

HIV Med. 2015 Apr;16(4):219-29. doi: 10.1111/hiv.12201. Epub 2014 Dec 18.

PMID:
25522796
6.

Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection.

Parsons V, Porter K, Gilson R, Hart G.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19732. doi: 10.7448/IAS.17.4.19732. eCollection 2014.

7.

Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study.

Daskalopoulou M, Rodger A, Thornton A, Phillips A, Sherr L, Gilson R, Johnson M, Fisher M, Anderson J, McDonnell J, Edwards S, Perry N, Collins S, Bhagani S, Speakman A, Smith C, Lampe F.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19630. doi: 10.7448/IAS.17.4.19630. eCollection 2014.

8.

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study.

Burch L, Smith C, Anderson J, Sherr L, Rodger A, O'Connell R, Gilson R, Elford J, Phillips A, Speakman A, Johnson M, Lampe F.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19533. doi: 10.7448/IAS.17.4.19533. eCollection 2014.

9.

Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men.

McDonnell J, Haddow L, Daskalopoulou M, Lampe F, Speakman A, Gilson R, Phillips A, Sherr L, Wayal S, Harrison J, Antinori A, Maruff P, Schembri A, Johnson M, Collins S, Rodger A; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):120-7. doi: 10.1097/QAI.0000000000000273.

10.

Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission.

Rodger AJ, Phillips A, Speakman A, Gilson R, Fisher M, Wilkins E, Anderson J, Johnson M, O'Connell R, Collins S, Elford J, Sherr L, Lampe FC; ASTRA (Antiretrovirals, Sexual Transmission Risk and Attitudes) Study Group.

PLoS One. 2014 May 28;9(5):e97340. doi: 10.1371/journal.pone.0097340. eCollection 2014.

11.

The contribution of viral genotype to plasma viral set-point in HIV infection.

Hodcroft E, Hadfield JD, Fearnhill E, Phillips A, Dunn D, O'Shea S, Pillay D, Leigh Brown AJ; UK HIV Drug Resistance Database; UK CHIC Study.

PLoS Pathog. 2014 May 1;10(5):e1004112. doi: 10.1371/journal.ppat.1004112. eCollection 2014 May.

12.

Calibration-free structured-illumination photoacoustic flowgraphy of transverse flow in scattering media.

Yao J, Gilson RC, Maslov KI, Wang L, Wang LV.

J Biomed Opt. 2014 Apr;19(4):046007. doi: 10.1117/1.JBO.19.4.046007.

13.

Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure.

Miltz A, Price H, Shahmanesh M, Copas A, Gilson R.

PLoS One. 2014 Mar 3;9(3):e90348. doi: 10.1371/journal.pone.0090348. eCollection 2014. Review.

14.

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women.

Huntington S, Thorne C, Anderson J, Newell ML, Taylor GP, Pillay D, Hill T, Tookey P, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study; National Study of HIV in Pregnancy and Childhood (NSHPC).

BMC Infect Dis. 2014 Mar 4;14:127. doi: 10.1186/1471-2334-14-127.

15.

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure.

Jose S, Hamzah L, Campbell LJ, Hill T, Fisher M, Leen C, Gilson R, Walsh J, Nelson M, Hay P, Johnson M, Chadwick D, Nitsch D, Jones R, Sabin CA, Post FA; UK Collaborative HIV Cohort Study Steering Committee.

J Infect Dis. 2014 Aug 1;210(3):363-73. doi: 10.1093/infdis/jiu107. Epub 2014 Feb 28.

16.

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.

Jose S, Quinn K, Hill T, Leen C, Walsh J, Hay P, Fisher M, Post F, Nelson M, Gompels M, Johnson M, Chadwick D, Gilson R, Sabin C, Fidler S; UK CHIC Steering Committee.

AIDS. 2014 Jun 1;28(9):1333-9. doi: 10.1097/QAD.0000000000000242.

17.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study.

AIDS. 2014 May 15;28(8):1193-202. doi: 10.1097/QAD.0000000000000243.

18.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.

O'Connor JL, Smith CJ, Lampe FC, Hill T, Gompels M, Hay P, Chadwick D, Fisher M, Ainsworth J, Gilson R, Mackie N, Anderson J, Orkin C, Nelson M, Kegg S, Leen C, Palfreeman A, Post F, Johnson M, Sabin CA, Phillips AN; UK Collaborative HIV Cohort (UK CHIC) Study Steering Committee.

AIDS. 2014 Mar 27;28(6):919-24. doi: 10.1097/QAD.0000000000000165.

PMID:
24335482
19.

The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations.

Samuel M, Jose S, Winston A, Nelson M, Johnson M, Chadwick D, Fisher M, Leen C, Gompels M, Gilson R, Post FA, Hay P, Sabin CA; UK Collaborative HIV Cohort Study.

HIV Med. 2014 May;15(5):311-6. doi: 10.1111/hiv.12103. Epub 2013 Nov 19.

20.

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.

Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database; UK CHIC study.

AIDS. 2013 Sep 10;27(14):2245-53. doi: 10.1097/QAD.0b013e3283636179.

PMID:
24157905
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk